TCOV
PGEN icon

Trust Company of Vermont’s Precigen PGEN Stock Holding History

Trust Company of Vermont’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$224 – 1080
2024
Q4 		$224 Hold
200
– – ﹤0.01% 1024
2024
Q3 		$189 Hold
200
– – ﹤0.01% 1020
2024
Q2 		$316 Buy
+200
New +$290 ﹤0.01% 864

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Trust Company of Vermont's PGEN Position: Q1 2025 in Review

Trust Company of Vermont sold out of Precigen (PGEN) in Q1 2025, closing a stake of 200 shares — an estimated $224 sold.

Trust Company of Vermont first reported a position in PGEN in Q2 2024 and held it in 3 quarters. The position peaked at $316 in Q2 2024. 138 funds tracked by Wall St. Rank hold PGEN as of Q1 2025.

  • Trust Company of Vermont reported no remaining Precigen position as of Q1 2025 after selling out during the quarter.
  • Trust Company of Vermont sold 200 Precigen shares in Q1 2025, an estimated $224.
  • Trust Company of Vermont first reported a position in Precigen in Q2 2024 and held it in 3 quarters.
  • Trust Company of Vermont's Precigen position peaked at $316 in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q1 2025.

Based on Trust Company of Vermont's 13F filing for Q1 2025, filed 24 Apr 2025.